Ergoteles’s Geron GERN Stock Holding History

Ergoteles’s Portfolio GERN Stock Details GERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-30,889	Closed	-$72K	–	1613
2022 Q3	$72K	Buy	+30,889	New	+$69.2K	﹤0.01%	1413
2022 Q2	–	Sell	-295,715	Closed	-$402K	–	1776
2022 Q1	$402K	Buy	295,715 +210,488	+247%	+$235K	0.02%	748
2021 Q4	$104K	Buy	+85,227	New	+$122K	﹤0.01%	1151

Other funds holding GERN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Ergoteles's GERN Position: Q4 2022 in Review

Ergoteles sold out of Geron (GERN) in Q4 2022, closing a stake of 30,889 shares — an estimated $72K sold.

Ergoteles first reported a position in GERN in Q4 2021 and held it in 3 quarters. The position peaked at $402K in Q1 2022. 185 funds tracked by Wall St. Rank hold GERN as of Q4 2022.

Ergoteles reported no remaining Geron position as of Q4 2022 after selling out during the quarter.
Ergoteles sold 30,889 Geron shares in Q4 2022, an estimated $72K.
Ergoteles first reported a position in Geron in Q4 2021 and held it in 3 quarters.
Ergoteles's Geron position peaked at $402K in Q1 2022.
185 funds tracked by Wall St. Rank held Geron as of Q4 2022.

Based on Ergoteles's 13F filing for Q4 2022, filed 14 Feb 2023.